Abstract. Glycoprotein llb-IRa (ctnbB3) and the vitronectin receptor (ct~B3), two integrins that share the common #3 subunit, have been reported to function as promiscuous receptors for the RGD-containing adhesive proteins fibrinogen, vitronectin, fibronectin, yon Willebrand factor, and thrombospondin. The present study was designed to establish a cell system for the expression of either GP IIb-IIIa or the vitronectin receptor in an otherwise identical cellular environment and to compare the adhesive properties of these two integrins with those of native GP IIb-iRa and the vitronectin receptor constitutively expressed in HEL cells or platelets. M21 human melanoma cells lack GP Hb-IIIa and use the vitronectin receptor to attach to vitronectin, fibrinogen, fibronectin, and yon Willebrand factor. To study the functional properties of GP IIb-IIIa in these cells, we transfected GP lab into M21-L cells, a variant of M21 cells (Cheresh, D. A., and R. C. Spiro. 1987. J. Biol. Chem. 262:17703-17711), which lack the expression of functional ctv and are therefore unable to attach to vitronectin, fibrinogen, and yon Willebrand factor. Transfectants expressing GP IIb were isolated by immunomagnetic beads and surface expression of the GP lib-IRa complex was documented by FACS analysis and immunoprecipitation experiments performed with 125I-labeled M21-L/ GP n'b cells. Comparative functional studies demonstrated that GP llb-IIIa expressed in M21-L/GPIlb cells as well as native GP Ilb-tlla constitutively expressed in HEL-5J20 cells (an HEL variant lacking ctv~3) mediated cell attachment to immobilized fibrinogen, but not to vitronectin or von WiUebrand factor, whereas the vitronectin receptor expressed in M21 cells and HEL-AD1 cells (an HEL variant expressing c~v/33) mediated cell attachment to fibrinogen, vitronectin, and von Willebrand factor. Similarly, PGl2-treated resting platelets attached to immobilized fibrinogen but not to vitronectin or von Willebrand factor, and this attachment could be inhibited by mAb A2A9 (directed against a functional site on the GP IIb-iRa complex). However, in contrast to platelets, which adhered to vitronectin and von Willebrand factor after stimulation by thrombin or PMA, activation of the protein kinase C pathway in M21-L/GP Ilb or HEL cells did not induce cell adhesion to vitronectin or von Willebrand factor. Our results therefore demonstrate (a) that while GP IIb-I]Ia in its inactive, resting form is capable of mediating adhesion of platelets to immobilized fibrinogen, it does not to other RGD-containing adhesive proteins such as von Willebrand factor and vitronectin, and (b) that GP Ilb-iRa expressed in nucleated cells has similar adhesive properties as does GP llbIRa in resting platelets but is not activated by platelet stimuli.
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I
NTEGRINS are a widely distributed family of cell surface proteins that evolved from a common ancestor to perform a variety of cellular adhesion functions (Hynes, 1987) . During hemostasis and thrombosis, integrins of the platelet membrane play an essential role in mediating adhesion of platelets to extracelhlar matrix proteins exposed at the site of injury of the vessel wall, as well as fibrinogendependent aggregation of platelets with each other (reviewed in Phillips et al., 1988) . Two /33 integrins of the platelet membrane, GPIIb-IlIa (ctnb/~3) and the vitronectin receptor (ctv/33), share the same/3 subunit and have ct subunits that are 36% homologous (Fitzgerald et al., 1987) . Both GP ITollIa and the vitronectin receptor (VnR) have been shown to function as promiscuous receptors for the adhesive proteins fibrinogen, vitronectin, von Willebrand factor, fibronectin, and thrombospondin involved in platelet-subendothelium and platelet-platelet interactions. The multiple ligand-binding capability of these receptors is due to their ability to bind to the Arg-Gly-Asp (RGD) recognition sequence (Ruoslahti and Pierschbacher, 1987) . Fibrinogen contains two RGD sequences in its Act chain, at residues 95-97 and 572-574 (Doolittle et al., 1979) . A second site on fibrinogen that binds to GP Ilb-llla is a 12-amino acid sequence located at the carboxy-terminus of the -/chain of fibrinogen (Kloczewiak et al., 1984) . This dodecapeptide sequence is not found in other adhesive proteins, but competes with RGD-containing peptides for binding to GP I/b-Ilia (l_atm et al., 1987) . Equilibrium binding studies have shown that GP Ilb-IIIa contains a single RGD binding site (Steiner et al., 1989) . On GP lab-Ilia and the VnR, this RGD binding site appears similar as photoaflinity cross-linking studies with ~25I-RGD containing peptides have identified the same domain on the 13 subunit for both receptors (D'Souza et al., 1988; Smith and Cheresh, 1988) . Despite the structural similarities and the apparent identity of the RGD-binding sites of GPilb-HIa and the VnR, differences in ligand-receptor interactions individualize the two receptors. In nucleated cells, the VnR function is constitutive, allowing it to function essentially as a cell adhesion receptor, whereas the receptor function of GPI/bIlia in platelets is manifest only after cell activation. VnRmediated attachment of endothelial cells to immobilized fibrinogen uses exclusively the RGD binding site, whereas GPl/b-ilIa mediated attachment of activated platelets to fibrinogen occurs not only via the RGD sites but also the dodecapeptide which has been found to cross-link primarily to GPIIb (D'Souza et al., 1990 ).
Receptor-ligand interaction studies for GP lib-Ilia and the VnR have been performed essentially by comparing the adhesive properties of different cell types expressing a given receptor or by using purified receptor assays. However, a major drawback of whole cell assays is the presence of multiple integrin receptors on a given cell (e.g., platelets express at least six integrins: GP Ilb-IIla, the VnR (Lam et al., 1989) , ~2~ , ~5/3~ (Piotrowicz et al., 1988) , a6/3~ (Hemler et al., 1988) . Purified receptor assays also have limitations as they do not take into account the microenvironment of the receptor in the plasma membrane, such as receptor-phospholipid interactions, receptor-cytoskeleton interactions, or conformational changes of the molecule that might be important for receptor activation and function, and indeed, functional differences depending on the microenvironment have been noted for the VnR otv/33 (Conforti et al., 1990 ) and for oe2Bt (Kirchhofer et al., 1989; Elites and Hemler, 1989) .
To gain some further insight in the functional properties of GP Ilb-IIIa and the VnR, a clear advantage for receptor-ligand binding studies would be the existence of stable cell models that express either GP I/b-Ilia or the VnR in an otherwise identical cellular environment. With the availability of complete cDNA sequences encoding integrin receptors, the design of such experimental cell models has now become possible and transient expression of recombinant platelet GP Iib-illa has been achieved in COS cells (O~l'oole et al., 1989) and human embryonic kidney ceils (Bodary et al., 1989) . However, these cell lines constitutively express a VnR that competes with recombinant GP lib-Ilia in adhesion assays designed to study functional properties of GP Iib-ilIa. Also, extensive structural studies of the recombinant receptor are limited by the small number of cells expressing the transfected receptor as well as their short life span. Here we describe the establishment of stable cell systems expressing either GP II'b-ilIa or the VnR in the same cellular environment. By studying the functional properties of recombinant GP IIb-illa expressed in M21-L cells and harive GP IIb-ilIa constitutively expressed in HEL cells and platelets, we demonstrate a new functional role of the inactive, resting form of GP l/b-Ilia in mediating cell attachment to immobilized fibrinogen, but not to other RGD-containing adhesive proteins such as vitronectin or yon Willebrand factor.
Materials and Methods

Cells and Cell Culture
Platelets were isolated from healthy adult donors by differential centrifngat.ion of whole blood anticongulated with 1/6 vol of acid/citrate/dextrose (71 mM citric acid, 85 mM sodium citrate, 110 mM glucose) and 1 #M PGI2 as previously described . The human melanoma cells M21 (called here M21-W for wild type) and M21-L are those described by Cheresh and Spiro (1987) . Two subelones of the initial HEL cell line (Martin and Papayannopoulou, 1982) were used: the clone HEL-5J20 has a high surface expression of GP llb-l]Ja and only background expression of the VnR, whereas the clone HEL-AD1 expresses equal amounts ofGP Ilb-HIa and the VnR. The cells were grown in RPMI medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (Gibco Laboratories), 100 U/ml of penicillin, and 100 ttg/ml of streptomycin in 5% CO2 in a fully humidified incubator at 37°C. COS-'/cells (SV40 transformed African green monkey kidney) (Gluzman, 1981) were grown in DME medium (Gibeo Laboratories) supplemented with 10% FCS and antibiotics as described above.
mAbs
The following mAbs were used in this study. S1 was produced in our laboratory and reacts with GP IIba in Western blot; SZ21 (Amac Corp., Westbrook, ME) is directed against GP IIIa; A2A9 is a complex-specific GP Ilb-nIa antibody (Bennett et al., 1983) , LM609 a complex-specific VnR antibody (Cheresh and Spiro, 1987) , and BIIG2 a complex-dependent llbronectin receptor antibody (Werb et al., 1989) . All mouse mAbs were isolated from ascites fluid and purified on a protein-A Scpharose immunoabsorbent (Pharmacia Fine Chemicals, Piscataway, NJ). The rat BIIG2 mAbs were purified from aseites fluid by ammonium sulfate precipitation followed by chromatography on a DEAE column.
Plasmid Construct
For plasmid construction, we used the expression vector pBJ1, which was kindly provided by Dr. Mark Davis (Stanford University School of Medicine). The pBJ1 vector is a modified form of the PeD-SRc~ expression cloning vector described by Takebe et al. (1988) that contains the simian virus 40 (SV40) early promoter and the R segment and part of the RU sequence (R-U5') of the long terminal repeat of the human T cell leukemia virus type 1 (HTLV-1). A human eDNA for GP lib was isolated from a commercially prepared HEL cell eDNA library (Stratagene Corp., La Jolla, CA) using an oligonucleotide probe, which represented the first 42 nucleotides of the published sequence ). An EcoRI-Hindlll fragment was subcloned into M13 mpl8 (Boehringer Mannheim Biochemicals, Indianapolis, IN), and the Y-end of the clone was completed using site-directed mutagenesis (Kunkel, 1985) . This involved adding 2 nucleotides, such that the GP lib eDNA contained nucleofides 1-3203 of the published sequence. The full-length GP lib coding sequence was inserted into the EcoRI site of the pBJ1 vector. The resulting plasmid, designated pBJI-GP Ilb, was characterized by restriction mapping and transient expression in COS cells.
Transfection of M21-L Cells
M21-L cells were transfected using the lipofection method (Feigner et al., 1987) . 48 h before transfection, 106 cells were plated on fibronectin-coated 100 nun dishes. At day 0, the cells were washed twice with serum-free RPMI medium and then incubated for 24 h with 20 ~tg of pB.I1-GP Iro plasmid DNA and 4/zg of pSVneo plasmid DNA, mixed in a 1:1 volume with lipofectin 0Bethesda Research Laboratories, Gaithersburg, MD) according to the manufacturer's procedure. The next day, complete medium was added and the cells allowed to grow for 4 more days. The cells were then detached with EDTA buffer, pH 7.4 (1 mM EDTA, [50 mM NaCi, 50 mM Hepes) and washed twice with RPMI medium. Transfected cells were selected for surface expression of GP Ilb-IIIa using mAb S1 and immunomngnetic beads coated with polyclonal rabbit anti-mouse IgG (Dynal Inc., Great Neck, NY). Briefly, the cells (106 cells/100 ~d) were incubated for 30 rain at4*C with 10/~g of SI-IgG, washed with RPMI and incubated for a further 30 min under gentle agitation at 4"C with 3 × l0 s immunomngnetic beads in a final volume of 2 ml. Magnetic bead cell rosettes were separated from negative cells using a magnetic particle concentrator (Dynal Inc.). The selected cells were then plated on fibrinogen-coated dishes. After 24 h, nonadherent cells were washed off. Adherent cells were grown to a higher cell density in the presence of 1 mg/mi of G418-sulfate (Gibco Laboratories) and reselected twice for GPfib-lIIa expression by fluorescenceactivated cell sorting.
COS Cell Transfection
COS-7 cells were transfected using the lipofection method. Briefly, 5 × 10 s cells were plated onto 90-ram culture dishes. When the cells had reached 70 % confluency, transfectiun was performed with 10/~g of pBII-GP fib plasmid DNA as described above. The cells were then metabolically labeled for 24--48 h after transfection and processed for irnmunoprecipitation experiments as described in the following section.
Immunofluorescence Analysis of Receptor Expression
GP Igo-HIa and VnR expression was analyzed on M21-L-transfected cells in suspension using indirect immunofluorescence and a fluorescenceactivated cell sorter (FACS 440; Becton-Dickinson Co., Mountain View, CA). Adherent cells were detached by incubating the cells for 5 min at 37°C with EDTA buffer. The cells were then immediately washed and resuspended in RPMI medium. These experimental conditions have previously been shown to induce only minimal irreversible GP ITo-Ilh complex dissociation in human platelets (Fitzgerald and Phillips, 1985) . The cells were f~rtber incubated at 40C for 30 rain at 106 cells/100/~1 in RPMI medium containing 10/~g of monoclonal mouse IgG. The cells were then washed with RPMI and incubated with FITC-cunjngated goat anti-mouse IgG (Cappel Laboratories, West Chester, PA) for 30 rain at 4"C. Positive fluorescence was determined on a four-decade log scale and expressed as channel number of mean intensity of fluorescence (MIF).I Background fluorescence was determined for each cell population using FITC-conjugated goat anti-mouse IgG alone. The cytometric data were obtained with the assistance of the UCSF Laboratory for Cell Analysis.
Cell Radiolabeling and Immunoprecipitation
For 12sI surface labeling, the evils were detached with EDTA buffer, washed twice with PBS and resnspended at 107 cells/mi in PBS. Labeling was performed by the laetoperoxidase catalyzed iodination procedure as previously described (Kieffer et al., 1986) . For steady state metabolic labeling, adherent cells were washed twice with RPMI medium and then cultured for 30 rain at 37"C in methionine and cysteine free RPMI medium supplemented with heat inactivated, dialyzed FCS. After 30 rain, 250 t~Ci [3SS]methionine and 250 t~Ci [3SS]eysteine (specific activity >800 Ci/mM; Amersham Corp., Arlington Heights, IL) were added to the medium and the cells cultured for 24 h at 37"C. The cells were then washed twice with RPMI, detached with EDTA buffer, and resuspended at 5 × 107 cells/ml in PBS. For immunoprecipitation, radiolabeled cells were lyzed in lysis buffer, pH 7.4 (10 mM Tris, 150 mM NaCI, 1% Triton X-100, 0.1% SDS, 2 raM PMSF). Triton X-100 insoluble material was removed by ultracentrifngation, and lysate samples, corresponding to 5 × 106 cells were incubated with 5/~g ofmAb IgO. After 3 h at 4"C, 25 t~l of protein A-Sepharose CL-4B (Pharmacia Fine Chemicals) were added and the incubation continued for 30 rain at 4"C. Protein A-Sepharose beads were washed six times with lysis buffer, and the final pellet resuspended in 50/~1 of 10 mM TrisHCl, pH Z4, containing 2% (wt/vol) SDS and 5% 2-mercaptoethanol. Bound proteins were eluted by boiling the suspension for 5 nfin and analyzed by SDS-PAGE according to the method of Laernmli (1970) . After electrophoresis, the gels were fixed and when required processed for fluorography with Amplify (Amersham Corp.). The gels were then dried and exposed at -800C to FUJI RX films.
1. Abbreviations used in this paper: GP, glycoprotein; MIF, mean fluorescence intensity; VnR, vitronectin receptor.
Cell Adhesion Assay
M21-L/GP IIb cells and M21-L cells were metabolically labeled overnight with [35S]methionine as described above and were then washed twice with RPMI medium. The cells were detached with EDTA buffer, washed and resuspended in RPMI medium at I06 cel]s/ml. Before the adhesion assay, the cells were incubated with I0/~g of the appropriate mAb or inhibitor for 30 rain at 4°C. The cells (5 x 104) were then added to individual wefts of microtiter plates previously coated with the adhesive protein (10/~g/rnl in RPMI medium). Cell attachment was allowed to occur at 37°C for 3 h, after which microtiter wells were washed with RPMI medium to remove unattached cells. The remaining cells were lyzed with 2 % SDS and radioactivity counted in a/~ scintillation counter (LS1701; Beckman Instruments, Palo Alto, CA). For platelet adhesion studies, platelets were isolated from blood collected in acid-citrate-dextrose anticoagulant containing 1 I~M PGI2 (Sigma Chemical Co., St. Louis, MO). After centrifugation of the blood at 160 g for 15 rain, the platelet rich plasma was removed and subjected to gel filtration over a Sepharose 2B column. Platelets were then pelleted and resuspended at 2 × l0 s cells per ml in 0.002 M Hepes, pH 7.35, conraining 0.15 M NaC1, 0.005 M dextrose and 1 mg/ml BSA. Platelets were activated with either 0.5 NIH unlts/ml of thrombin or 50/~M PMA for 10 rain at 220C or treated with 1 #M PG12, and the adhesion assay performed as described by Cheresh et al. (1989) . The adhesive proteins flbrinogen, vitronectin, and fibronectin were purified from human plasma according to published procedures (Kazal et al., 1963; Engvall et ai., 1978; Yatohga et al., 1988) , and were essentially devoid of contaminating proteins as determined by SDS-PAGE and Coomussie blue staining of the gel. BSA (fraction V) was purchased from Sigma Chemical Co.
Results
Transfection of GPIIb cDNA into M21-L Cells
As previously reported by Cheresh and Spiro (1987) , M21-L cells are a variant cell clone of the human melanoma cell line M21 and lack the VnR o~ chain or its mRNA but do produce normal levels of the/33 chain that accumulates within the cell. A full-length eDNA clone containing the entire coding sequence of GP lib was constructed as described in the Materials and Methods section, subcloned into the expression vector pBJl, and introduced into the M21-L adherent cells using lipofectin. To select for transfected M21-L cells expressing a fully complexed GP Ilb-HIa receptor, positive transfectants were immunoselected using GP llb mAb S1 and immunomagnetic beads coated with rabbit anti-mouse IgG. A typical result is illustrated in Fig. 1 , which shows a few rosette-forming cells and a nonnegligible number of negative cells, most likely entrapped in the pellet of free magnetic beads (Fig. 1 A) . Selected transfectants were thereafter plated on fibrinogen-coated microtiter wells. The rosette forming cells were found to attach and spread, whereas the negative cells did not and thus could be partially washed off (Fig. 1  B) . The selected cells were then grown to a higher cell density, reselected twice by cell sorting using mAb S1 and finally subcloned by limiting dilution.
Surface Expression of the GP lib-Ilia Complex in M21-L Cells Transfected with GP lib
To study the surface expression of the GP llb-IIIa complex in transfected M21-L/GP Hb cells, indirect immunofluorescence was performed on cells in suspension using monoclonal antibodies specific for either the GP lib subunit (S1) or the GP Hb-l~a complex (A2A9) and analyzed on a fluorescence-activated cell sorter. The results shown in Table  I 
Biosynthesis and Posttranslational Processing of GP lib in M21-L/GP lib Cells as Compared with COS/GP lib Cells
As a prelude to functional analysis of the transfected protein, experiments were performed to determine whether posttranslational processing of GP fib had occurred. A simple procedure to demonstrate posttranslational processing of a glycoprotein is based on the change of its molecular weight, visualized by a change in the electrophoretic mobility of the glycoprotein when submitted to SDS-PAGE analysis. To determine whether posttranslational processing of GP fib-IIIa occurred in M21-L/GP IIb cells, we compared the apparent molecular weight of GP fib or GP I~a immunoprecipitated from transfected M21-L/GP fib cells and COS/GP fib cells as well as cells that constitutively express GP Ilb-IIIa, such as platelets or HEL cells. In an initial experiment shown in Fig. 2 , M21-L/GP fib cells and platelets were ~"I-surface labeled, lysed and immunoprecipitated with the GP fib-Ilia mAb A2A9. Under nonreducing conditions, the precipitated GP lib-Ilia from M21-L/GP llb cells had a molecular mass of 140,000 and 95,000 respectively and comigrated with platelet GP fib and GP ll]a 0anes A-C). After disulfide cleavage, the electrophoretic mobility of both subunits underwent the characteristic shift identical to that observed for platelet GP fib and GP Ilia, with the appearance of the GP fib/3 subunlt (lanes D-F) . A similar result was obtained when GP fib-IRa from M2bL/GP fib was compared with HEL cell GP Ilb-ma (data not shown). Thus, GPIlb in M21-L/GP Ilb cells had undergone posttranslational cleavage. In contrast, when experiments were performed using metabolically labeled COS cells that had been transfected with the same pBJ1/GP fib vector, only unprocessed pro-GP fib was immunoprecipitated with mAh $1, whereas the same mAh precipitated pro-GP fib as well as the processed GP llb-lBa complex from metabolically labeled HEL cells (Fig. 3) . These results thus provide evidence that normal posttranslational proteolytic processing of GP fib into its ot and (1989) have shown that tunicamycin-treated megakaryocyte GP Rb-IRa has an increased electrophoretic mobility as compared with normal GP l/b-IRa. To exclude the possibility that our selection procedure allowed the isolation of a revertant M21-L cell expressing the VnR, and to further document biosynthesis of GP l/b-IRa, immunoprecipitation experiments were performed using steady-state metabolically labeled M21-L/GP IIb cells. The result is shown in Fig. 4 . No VnR could be immunoprecipitated from M21-L/GP I~ cells, whereas mAb A2A9, S1, and SZ21 all precipitated two bands corresponding to GP fibIRa. Immunoprecipitations performed on M21-W and M21-L cells confirmed their typical phenotype, i.e., the presence of the VnR in M21-W cells and the free/~3 subunit in M21-L cells.
Functional Properties of GP lib-Ilia in M21-L/GP lib Cells, HEL Cells, and Platelets (a) GP lib-Ilia Expressed in M21-L Cells Mediates Cell Attachment to Fibrinogen But Not to Vitronectin, von
Vdllebrand Factor, or Fibronectin. To study the functional properties of GP Hb-IIIa and the VnR individually expressed in M21 melanoma cells, a cell adhesion assay was performed on microtiter plates coated with various adhesive proteins (Fig. 5 ). In accordance with previous results (Cheresh and O Spiro, 1987) , M21 cells expressing the VnR attached to o fibrinogen, vitronectin, von Willebrand factor, and fibronec-× tin, whereas mock transfected M21-L ceils, which express ob/31, only attached to fibronectin. When M21-L/GP lib transfectants were tested, they attached to fibrinogen as well as fibronectin, however, they did not attach to vitronectin or z:E von Willebrand factor, nor could adhesion to vitronectin or ,~ von Willebrand factor be induced by PMA. (result not ~' < shown). To determine whether the M21-L/GP lib cell inter-= action with fibrinogen or fibronectin was GP l/b-IRa depen-S, dent, experiments were performed in the presence of mAb known to inhibit this interaction or a peptide containing the RGD sequence. The results are shown in Fig. 6 . Pretreatment of M21-L/GP lib cells with mAb A2A9 inhibited their attachment to fibrinogen. This inhibition was specific since neither the FnR MoAb BIIG2 nor the VnR MoAb LM609 had an inhibitory effect. Attachment was also inhibited by RGDS but not by RGES at a final concentration of 50 ~M. When plated on fibronectin, MoAb A2A9 had no effect whereas the MoAb BIIG2 inhibited M21-L/GP llb cell adhesion to a similar extent as RGD. Conversely, pretreatment of mock-transfected M21-L cells with BIIG2 inhibited their attachment to fibronectin, whereas mAb LM609 or A2A9 had no effect (results not shown).
(b) Properties of GP lib-Ilia and the Vitronectin Receptor Constitutively Expressed in Nucleated Cells.
To determine whether the functional properties of the GP IIb-iRa in M21-L/GP llb cells corresponded to those of native GP llbIRa constitutively expressed in nucleated cells, we compared those ofa subclone of the HEL cell line selected for high expression of GP I1b-iRa and low expression of the VnR. As shown in Fig. 7 , the subclone HEL-5J20 is characterized by a high expression of GP llb-IIIa and only background expression of the VnR, whereas the subclone HEL-AD1 expresses similar amounts of both GP I/b-Ilia and the VnR. When the two HEL clones were studied for their adhesion properties, HEL-5J20 cells attached to fibrinogen but not to vitronectin or von Willebrand factor, whereas HEL-AD1 cells attached to all ligands (Fig. 8) . Interestingly, similar to M21-L/GP fib cells, adhesion to vitronectin or von Willebrand factor could not be induced through activation of the protein kinase C pathway by PMA (data not shown). Together, these results provide evidence that in contrast to the VnR, GP IIb-IHa expressed in nucleated cells mediates exclusively attachment to fibrinogen.
(c) Resting Platelet GP lib-Ilia Mediates Platelet Adhe-
sion to Immobilized Fibrinogen. GP llb-lTta-mediated platelet adhesion to immobilized adhesive proteins is known to be activation dependent and adhesion assays are most commonly performed with thrombin-activated platelets (Haverstick et al., 1985; Santoro and Cowan, 1986; . To determine whether GP Wo-l]Ia in its resting inactive form was able to mediate platelet attachment to immobilized fibrinogen, we compared the adhesive properties of platelets isolated in the presence of PGI2 with those of platelets activated with thrombin or PMA. As shown in Fig.  9 , resting PGI2-treated platelets attached to fibrinogen but not to vitronectin or yon Willebrand factor, whereas thrombin- or PMA-activated platelets attached to fibrinogen, vitronectin, and von Wfllebrand factor. Also, attachment of PGI2-treated as well as PMA-treated platelets to fibrinogen could be inhibited by mAb A2A9 as well as the RGDS peptide (resuits not shown).
Discussion
This study compares the adhesive activities of GI? l/b-IRa and the VnR on control, inactivated cells. Three approaches were used to characterize these properties. First, an expression system was established so that the adhesive properties of GP l/b-RIa and the VnR could be compared in an otherwise identical cellular environment. As previously described (Cheresh and Spiro, 1987) , the VnR in M21 cells mediated cellular adhesion to fibrinogen, yon Willebrand factor and vitronectin. To measure the adhesive activity of GP l/b-IRa in these same cells we have expressed GP llb in human M21-L cells which synthesize f33 but lack expression of the VnR. GP l/b-IRa in these cells, termed M21-L/GP lib, mediated cellular adhesion to fibrinogen but not to von grdlebrand factor or vitronectin. Second, variants of HEL cells were selected so that the adhesive activities of GP lib-IRa and the VnR could be compared in another cell type. It was found that while the VnR mediated cellular adhesion to fibrinogen, yon Wtllebrand factor, and vitronectin, GP llbIRa selectively mediated cellular adhesion to fibrinogen. The third approach examines the ability of GP IIb-IRa to mediate the adhesion of unstimulated platelets to adhesive proteins. Although GP IIb-l/Ia on activated platelets binds the soluble form of the three adhesive proteins examined (reviewed in Plow et al., 1986) , GP l/b-IRa on control platelets only mediated platelet adhesion to fibrinogen. We conclude that the adhesive properties of GP Rb-iRa on unstimulated platelets and nucleated cells is similar, selectively mediating cellular adhesions to fibrinogen, and distinct from those of the VnR which mediate cellular adhesions in addition to yon Willebrand factor and vitronectin. The present study was facilitated by the stable transfection of full-length cDNA coding GP ]To into M21-L cells. The GP IIb-iRa expressed on the surface of these cells after transfection of GP IIb used the endogenous 133 (GPIRa) that these cells synthesized. Immunomagnetic bead selection rather than FACS was used for the initial isolation of transfectants expressing GP lib-Ilia. This was particularly useful since the beads provide a quick, inexpensive method that allowed easy isolation of the GP l/b-IRa positive cells and convenient visualization of the morphologic changes that occurred when the selected cells were cultured on fibrinogen-coated plates. Although the beads remained bound to the cells for several days, they apparently did not interfere with cell attachment and spreading, cell growth, or cell division. This immunomagnetic bead selection procedure might be useful for other adhesive protein receptor expression systems and represents an alternative method for the selection of stable transfectants. Immunological criteria were also used to show that the expressed protein in M21-L/GP IIb cells does indeed correspond to platelet GP l/b-IRa rather than a revertant endogenous VnR. Neither M21-L ceils nor M21-L/GP lTo cells bound the rnAb LM609, which recognizes a complexdependent epitope of the VnR on M21-wild-type cells. In addition, mAb LM609 was unable to immunoprecipitate a complex from metabolically labeled M21-L or M21-L/GP l/b cells, providing further evidence that these cells are devoid of an intracellular pool of the VnR. In contrast, mAb A2A9, which recognizes a complex-dependent determinant on GP l/b-IRa and does not cross-react with the VnR, exclusively reacted with the transfected M21-L/GP IIb cells from which it precipitated a complex corresponding to GP HbIRa. Finally, mAb SZ21, which reacts with the individual /33 subunit common to GP IIb-IRa and the VnR, precipitated the VnR only from M21-wild type cells, the free/33 subunit from M21-L cells and the GP IIb-IRa complex only from the transfected M21-L/GP lib cells. These results provide evidence that our initial immunomagnetic bead cell enrichment method allowed successful identification and isolation of GP IIb-expressing M21-L ceils.
Transfection of GP IIb into M21-L cells allowed complete posttranslational processing and surface expression of a GP l/b-IRa complex. This was documented by immunoprecipitation experiments performed in parallel on 125I-surface labeled or [3~S]methionine labeled cells, t2SI-labeled GP l/bIRa from M21-L/GP l/b ceils comigrated with platelet GP l/b-iRa under both nonreducing and reducing conditions providing evidence that only the fully processed receptor reached the cell surface. The inability of mAb S1 (which reacts with individual GP IIb as well as pro-GP l/b) to precipitate pro-GP llb from steady-state [35S]methioninelabeled M21-L/GP llb cells demonstrates the absence of an intracellular pool of unprocessed pro-GP l/b and suggests that pro-GP lib did associate with endogenous GP IRa to form the GP lib-IRa complex. This is in contrast with our results obtained after transient expression of the same pBJ1-GP lib construct in COS cells where only individual unprocessed pro-GP Ub could be immunoprecipitated with mAb S1. In HEL cells, mAb SI precipitated pro-GP Wo as well as the processed GP IIb-IRa complex (Fig. 3) . Since COS cells express a dimeric complex immunologically related to the integrin/33 subunit, as identified by Western blot analysis and immunoprecipitation experiments using polyclonal rabbit IgG directed against GP lib-IRa (Kieffer, N., and D. R. Phillips, unpublished results), these results suggest that human c, n~ does not associate with monkey B3 unlike murine od and avian B~, which do (Solowska et al., 1989) .
The successful stable expression of GP llb-~Ia in M21-L cells allowed us to compare the functional properties of GPHb-ma and the VnR individually expressed in M21 cells, and to compare these properties with those of native GP libIlia constitutively expressed in HEL ceils or platelets. For this purpose, subclones of the HEL cell line were selected that express either GP llb-llla (HEL-5J20) or GP IIb-IIIa and the vitronectin receptor (HEL-AD1). By using two distinct cell systems as well as human platelets, we have been able to demonstrate that GP l/b-IIIa in its inactive, resting form is capable of mediating cell attachment to immobilized fibrinogen, but not to other RGD-containing adhesive proteins such as vitronectin or von Wtllebrand factor. Evidence to support this conclusion is derived from the following experiments. First, M21-L/GP lib cells as well as HEL cells expressing GP IIb-llla attached to fibrinogen but not to vitronectin or von Willebrand factor, whereas HEL-AD1 cells and M21 cells expressing the VnR did. Second, M21-L/GP llb cell-, HEL cell-or platelet interaction with immobilized fibrinogen could be specifically inhibited with a complex dependent anti-GP I/b-IIIa mAb, demonstrating that the observed cell attachment to fibrinogen was GP IibIIIa dependent. Third, in contrast to thrombin or PMA-actirated platelets, which attach to RGD-containing adhesive proteins such as fibrinogen, vitronectin, or von Willebrand factor, PGI2-treated resting platelets attached exclusively to immobilized fibrinogen. Finally, that PMA did not induce M21-L/GP llb or HEL cell attachment to vitronectin or yon Willebrand factor suggests that in nucleated ceils, GP HbIIIa is blocked in a functional state similar to that of resting platelets.
Since resting platelets and nucleated cells expressing GP l/b-lIIa attach to immobilized fibrinogen but are unable to bind soluble fibrinogen (Coller, 1980; Marguerie et al., 1979; Thiagarajan e1 al., 1987; Kieffer, N., and D. R. Phillips, unpublished results) , the molecular mechanism underlying soluble versus immobilized fibrinogen/GP IIb-iRa interaction must be distinct. Cheresh et al. (1989) have recently shown that vitronectin receptor-dependent endothelial cell adhesion to immobilized fibrinogen is exclusively mediated through the RGD-containing site near the COOH terminus of the fibrinogen Aot chain, whereas GP Ilb-iRa-mediated adhesion of activated platelets to fibrinogen involves either RGD sequences as well as the COOH terminus portion of the 3' chain. Our results suggest that in contrast to activated platelets, GP 11b-HIa mediated attachment of resting platelets to immobilized fibrinogen might be mediated through the dodecapeptide sequence of the fibrinogen 3' chain, since this sequence is unique to fibrinogen among the adhesive proteins, whereas GP IIb-lIIa-mediated adhesion to other adhesive proteins such as vitronectin or yon Willebrand factor is dependent on the RGD recognition sites and requires the activated form of GP 11b-lTla. Shiba et al. (Shiba, E., J. Lindon, M. Kloczawiak, J. Hawiger, G. Matsueda, B. Kudryk, and E. W. Salzman. 1988. Circulation. 78:11662.) have indeed shown that antibodies generated against the peptide 385-411 of the fibrinogen 3' chain are effective in blocking the interaction of human platelets with fibrinogen adsorbed to a synthetic polymer surface. Alternatively, conformational changes of the RGD sequence in immobilized fibrinogen might increase its affinity for resting GPllb-11Ia. Together with the data of Lindon et al. (1986) , it is therefore tempting to speculate that changes in the conformation of immobilized fibrinogen lead to the exposure of recognition sites (3' chain dodecapeptide and/or a high-affinity RGD site) which are not accessible on soluble fibrinogen. Finally, due to the high density of immobilized fibrinogen molecules, several unidentiffed binding sites with modest affinities might cooperate to function as multivalent ligands for resting GP fib-Ilia and allow a sufficiently high degree of adhesive specificity and affinity.
The expression of immunoreactive and functional GP fibIlia on M21-L/GP fib cells provides evidence that a transfected exogenous ot ab subunit can form heterodimers with an existing endogenous VnR/~3 subunit and rescue a fully complexed c~nb/33 receptor on the cell surface. This result is of particular interest with respect to patients with the genetic integrin deficiency Glanzmann's thrombasthenia, an autosomal recessive hemorrhagic disorder caused by a quantitative or qualitative defect of GP fib-iRa to bind fibrinogen (for a review see George et al., 1990) . Although the molecular basis for GP fib-iRa deficiency in thrombasthenic patients is still unclear, the biosynthetic pathway of GP fib-IRa (Bray et al., 1986 , Duperray et al., 1987 Rosa et al., 1989) suggests that a defect in only one of the glycoprotein subunits would prevent the formation of the complex and its insertion into the membrane. Indeed, in several thrombasthenic patients characterized by a complete absence of surface expression of the GP fib-IRa complex, trace amounts of GP fib and GP HIa or GP IRa alone could be detected by immunoblotting (Nurden et al., 1985; Coller et al., 1987) . Also, normal expression of the VnR (otv/33) in endothelial cells of a patient lacking platelet GP fib-IHa suggest that this type of thrombasthenia is caused by defective synthesis of GP fib (Giltay et al., 1987) . M21-L cells, which have an intracellular pool of free GP Ilia, mimic the GP lTo-defective type of Glanzmann's thrombasthenia, and thus constitute an exceUent human experimental cell model for integrin gene therapy in this disease.
Finally, our data provide a molecular model for the understanding of some physiological aspects of hemostasis and thrombosis. The interaction of resting platelet GP nb-ltla with immobilized fibrinogen constitutes a possible mechanism by which unactivated platelets are recruited into growing thrombi. Since this mechanism might also play a key role in platelet adhesion to artificial surfaces used for prosthetic arterial grafts or dialysis membranes McManama et al., 1986) , the design of artificial surfaces resistant to fibrinogen adsorption appears to be a,prerequisite for the development of nonthrombogenic materials.
